|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0020792,
umls-concept:C0030685,
umls-concept:C0035820,
umls-concept:C0040732,
umls-concept:C0086418,
umls-concept:C0205210,
umls-concept:C0243161,
umls-concept:C0391871,
umls-concept:C0521116,
umls-concept:C0680255,
umls-concept:C1283071,
umls-concept:C1514468,
umls-concept:C1521827,
umls-concept:C1963578
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2004-7-14
|
|
pubmed:abstractText |
Alloimmunity, autoimmunity, and nonspecific inflammation are known to be potential determinants for long-term islet survival and insulin independence. Sufficient islet mass is a key determinant. But islet engraftment and posttransplant survival may also depend on functional characteristics of the graft. This study investigated the significance of current product release criteria for the transplantation outcome.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0041-1345
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2004 Elsevier Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1528-31
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
The role of current product release criteria for identification of human islet preparations suitable for clinical transplantation.
|
|
pubmed:affiliation |
3rd Medical Department, Center of Internal Medicine, University Hospital, Giessen, Germany. michael.eckhard@innere.med.uni-giessen.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
